LEILA CORKER: Open Payments
NPI 1841951282 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $1,249
Food & beverage: $1,172Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $323 |
| ABBVIE INC. | 12 | $163 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $159 |
| Gilead Sciences, Inc. | 2 | $147 |
| Ethicon US, LLC | 1 | $94 |
| Madrigal Pharmaceuticals | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| QOL Medical, LLC | 2 | $59 |
| Ardelyx, Inc. | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
Products named: TREMFYA, XIFAXAN, Livdelzi, LINX REFLUX MANAGEMENT SYSTEM, RINVOQ, REZDIFFRA, ENTYVIO, Sucraid.
Industry payments across VA — which companies pay providers there.
